These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 986665)

  • 1. Effects of delta9-tetrahydrocannabinol on social behaviour in mice: comparison between two vehicles.
    Dorr M; Steinberg H
    Psychopharmacology (Berl); 1976 May; 47(1):87-91. PubMed ID: 986665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Sci; 1974 Jun; 63(6):939-41. PubMed ID: 4851104
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of delta-9-tetrahydrocannabinol on social behaviour in the laboratory mouse and rat.
    Cutler MG; Mackintosh JH
    Psychopharmacologia; 1975 Nov; 44(3):287-9. PubMed ID: 1239783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four vehicles for intraperitoneal administration of -tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Pharmacol; 1971 Nov; 23(11):889-91. PubMed ID: 4400204
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vehicle and route of administration as parameters affecting operant behavioral effects of 9 -tetrahydrocannabinol.
    Borgen LA; Davis WM
    J Pharm Sci; 1973 Mar; 62(3):479-80. PubMed ID: 4691712
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats.
    Wada JA; Wake A; Sato M; Corcoran ME
    Epilepsia; 1975 Sep; 16(3):503-10. PubMed ID: 1183427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic activity of cannabinoids.
    Munson AE; Harris LS; Friedman MA; Dewey WL; Carchman RA
    J Natl Cancer Inst; 1975 Sep; 55(3):597-602. PubMed ID: 1159836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precoital single doses of delta9-tetrahydrocannabinol block ovulation in the rabbit.
    Asch RH; Fernandez EO; Smith CG; Pauerstein CJ
    Fertil Steril; 1979 Mar; 31(3):331-4. PubMed ID: 374129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.
    Blumstein GW; Parsa A; Park AK; McDowell BL; Arroyo-Mendoza M; Girguis M; Adler-Moore JP; Olson J; Buckley NE
    PLoS One; 2014; 9(7):e103288. PubMed ID: 25057822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.
    Miczek KA
    Psychopharmacology (Berl); 1979 Jan; 60(2):137-46. PubMed ID: 106423
    [No Abstract]   [Full Text] [Related]  

  • 19. Time course of delta9-tetrahydrocannabinol inhibition of predatory aggression.
    Kilbey MM; Johnson KM; McLendon DM
    Pharmacol Biochem Behav; 1977 Aug; 7(2):117-20. PubMed ID: 562518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.